Found: 2
Select item for more details and to access through your institution.
Progression-free survival shortens after each relapse in patients with follicular lymphoma treated in the rituximab era.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 360, doi. 10.1002/hon.2439_115
- By:
- Publication type:
- Article
CD30 expression in diffuse large B-cell lymphoma correlates with non- GCB subtype but does not have prognostic impact in patients treated with first line R-CHOP/ R-CHOP-like.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 290, doi. 10.1002/hon.2439_19
- By:
- Publication type:
- Article